Qualigen Therapeutics Inc (QLGN)
0.2996
-0.01
(-3.01%)
USD |
NASDAQ |
Apr 25, 16:00
0.2996
0.00 (0.00%)
After-Hours: 20:00
Qualigen Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -212.9% |
| March 31, 2023 | -239.3% |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | -288.2% |
| March 31, 2022 | -598.3% |
| December 31, 2021 | -284.8% |
| Date | Value |
|---|---|
| September 30, 2021 | -263.0% |
| June 30, 2021 | -482.9% |
| March 31, 2021 | -193.3% |
| September 30, 2020 | -968.5% |
| June 30, 2020 | -2.06K% |
| September 30, 2019 | -29.66% |
| June 30, 2019 | -39.35% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.06K%
Minimum
Jun 2020
-29.66%
Maximum
Sep 2019
-471.3%
Average
-273.9%
Median
Profit Margin (Quarterly) Benchmarks
| Marizyme Inc | -17.88K% |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | -19.35K% |
| IGC Pharma Inc | -2.74K% |
| NovaBay Pharmaceuticals Inc | -110.2% |